Progesterone receptor antagonists and progesterone receptor modulators for endometriosis
This review protocol outlines an assessment of the effectiveness and safety of progesterone receptor antagonists and modulators for pain relief in women of reproductive age with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (18)
- Endometriosis via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Laparoscopy in the diagnosis and management of pelvic pain in adolescents. via openalex
- Mifepristone. Auxiliary therapeutic use in cancer and related disorders. via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Progesterone antagonists and progesterone receptor modulators: an overview via openalex
- The Epidemiology of Endometriosis via openalex
- Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil via openalex
- W6602190664 via openalex
- W6607958688 via openalex
- W6824748752 via openalex
- W1910306760 via openalex
- W1982488750 via openalex
- W2056447394 via openalex
- W2090345475 via openalex
- W2100281208 via openalex
- W2122896665 via openalex
- W4241635711 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-08-16T06:22:10.609676+00:00